ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
hsa05323	Rheumatoid arthritis	10/41	93/8661	1.06014934157928e-11	1.4736075847952e-09	9.3739520729115e-10	CXCL3/CXCL2/CCL3L1/IL6/CXCL1/TNF/IL1A/IL1B/CXCL8/CCL3	10
hsa04061	Viral protein interaction with cytokine and cytokine receptor	10/41	100/8661	2.21975498271124e-11	1.54272971298431e-09	9.81365360777601e-10	CXCR1/CXCL3/CCL18/CXCL2/CCL3L1/IL6/CXCL1/TNF/CXCL8/CCL3	10
hsa04060	Cytokine-cytokine receptor interaction	13/41	297/8661	5.19274209337795e-10	2.40597050326512e-08	1.53049240646929e-08	CXCR1/CXCR6/CXCL3/CCL18/CXCL2/CCL3L1/IL6/CXCL1/TNF/IL1A/IL1B/CXCL8/CCL3	13
hsa05134	Legionellosis	7/41	56/8661	6.08568237683063e-09	2.11477462594864e-07	1.34525610435203e-07	CXCL3/CXCL2/IL6/CXCL1/TNF/IL1B/CXCL8	7
hsa04657	IL-17 signaling pathway	8/41	94/8661	1.0139150652407e-08	2.81868388136915e-07	1.79302874695198e-07	CXCL3/CXCL2/IL6/CXCL1/TNF/PTGS2/IL1B/CXCL8	8
hsa04668	TNF signaling pathway	8/41	114/8661	4.68180636824858e-08	1.08461847531092e-06	6.89950412162949e-07	CXCL3/SOCS3/CXCL2/IL6/CXCL1/TNF/PTGS2/IL1B	8
hsa04062	Chemokine signaling pathway	9/41	192/8661	2.0349140101016e-07	4.04075782005889e-06	2.57041769697044e-06	CXCR1/CXCR6/CXCL3/CCL18/CXCL2/CCL3L1/CXCL1/CXCL8/CCL3	9
hsa05146	Amoebiasis	7/41	102/8661	4.13377992156958e-07	7.18244261372714e-06	4.56891465015585e-06	CXCL3/CXCL2/IL6/CXCL1/TNF/IL1B/CXCL8	7
hsa04064	NF-kappa B signaling pathway	7/41	104/8661	4.7224864099049e-07	7.29361789974201e-06	4.63963577113464e-06	CXCL3/CXCL2/CXCL1/TNF/PTGS2/IL1B/CXCL8	7
hsa05417	Lipid and atherosclerosis	9/41	215/8661	5.32092195650886e-07	7.39608151954732e-06	4.70481520364994e-06	CXCL3/CXCL2/CCL3L1/IL6/CXCL1/TNF/IL1B/CXCL8/CCL3	9
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	6/41	70/8661	8.0649771863442e-07	1.01911984445622e-05	6.48285247514749e-06	CXCR1/CXCL3/CXCL2/HBEGF/CXCL1/CXCL8	6
hsa04936	Alcoholic liver disease	7/41	142/8661	3.87415298451294e-06	4.48756054039415e-05	2.85463904122006e-05	CXCL3/CXCL2/IL6/CXCL1/TNF/IL1B/CXCL8	7
hsa05142	Chagas disease	6/41	102/8661	7.40994562474747e-06	7.92294186030691e-05	5.03996301602257e-05	CCL3L1/IL6/TNF/IL1B/CXCL8/CCL3	6
hsa04620	Toll-like receptor signaling pathway	6/41	108/8661	1.03124857223903e-05	0.000102388251100875	6.51314887729915e-05	CCL3L1/IL6/TNF/IL1B/CXCL8/CCL3	6
hsa04621	NOD-like receptor signaling pathway	7/41	186/8661	2.28087507939853e-05	0.00021136109069093	0.000134451583627703	CXCL3/CXCL2/IL6/CXCL1/TNF/IL1B/CXCL8	7
hsa05133	Pertussis	5/41	76/8661	2.66742869341008e-05	0.000231732867740001	0.000147410533056873	IL6/TNF/IL1A/IL1B/CXCL8	5
hsa05332	Graft-versus-host disease	4/41	42/8661	4.24809196520058e-05	0.000347343990095812	0.000220953390140464	IL6/TNF/IL1A/IL1B	4
hsa05163	Human cytomegalovirus infection	7/41	225/8661	7.70272385597103e-05	0.000584543840033266	0.000371841594568681	CCL3L1/IL6/TNF/PTGS2/IL1B/CXCL8/CCL3	7
hsa04932	Non-alcoholic fatty liver disease	6/41	155/8661	7.99016759757702e-05	0.000584543840033266	0.000371841594568681	SOCS3/IL6/TNF/IL1A/IL1B/CXCL8	6
hsa05144	Malaria	4/41	50/8661	8.50484120962573e-05	0.000591086464068988	0.000376003506109769	IL6/TNF/IL1B/CXCL8	4
hsa04933	AGE-RAGE signaling pathway in diabetic complications	5/41	100/8661	0.000100014292642244	0.000661999365584375	0.000421112811125237	IL6/TNF/IL1A/IL1B/CXCL8	5
hsa05164	Influenza A	6/41	171/8661	0.000137515213589842	0.00086884612222673	0.000552692724475921	SOCS3/IL6/TNF/IL1A/IL1B/CXCL8	6
hsa05321	Inflammatory bowel disease	4/41	65/8661	0.000237538876037342	0.00143556103344307	0.000913192933049737	IL6/TNF/IL1A/IL1B	4
hsa05167	Kaposi sarcoma-associated herpesvirus infection	6/41	194/8661	0.000273510422716724	0.00158408119823436	0.00100766997843004	CXCL3/CXCL2/IL6/CXCL1/PTGS2/CXCL8	6
hsa01523	Antifolate resistance	3/41	30/8661	0.000365833623537386	0.00203403494686786	0.00129389576324802	IL6/TNF/IL1B	3
hsa05140	Leishmaniasis	4/41	77/8661	0.00045574141623226	0.0024364637252417	0.00154988983657934	TNF/IL1A/PTGS2/IL1B	4
hsa05143	African trypanosomiasis	3/41	37/8661	0.000684218106458286	0.00352245617769266	0.00224071426676398	IL6/TNF/IL1B	3
hsa04940	Type I diabetes mellitus	3/41	43/8661	0.00106554980159893	0.00528969365793754	0.0033648941103124	TNF/IL1A/IL1B	3
hsa04640	Hematopoietic cell lineage	4/41	99/8661	0.00117610781151251	0.0056372064069048	0.00358595485179858	IL6/TNF/IL1A/IL1B	4
hsa04625	C-type lectin receptor signaling pathway	4/41	104/8661	0.00141233268131682	0.00654380809010126	0.00416266474493378	IL6/TNF/PTGS2/IL1B	4
hsa04380	Osteoclast differentiation	4/41	135/8661	0.00365759124949821	0.016400167215492	0.0104325183347317	SOCS3/TNF/IL1A/IL1B	4
hsa05135	Yersinia infection	4/41	137/8661	0.0038554637642531	0.0167471707259744	0.0106532551380678	IL6/TNF/IL1B/CXCL8	4
hsa05418	Fluid shear stress and atherosclerosis	4/41	139/8661	0.00406050368417891	0.0171033337000263	0.0108798184839244	DUSP1/TNF/IL1A/IL1B	4
hsa05171	Coronavirus disease - COVID-19	5/41	232/8661	0.00450850094914288	0.0184318127038488	0.0117248941092261	HBEGF/IL6/TNF/IL1B/CXCL8	5
hsa04012	ErbB signaling pathway	3/41	85/8661	0.00743362638524932	0.0295221162157044	0.0187796877101035	HBEGF/EREG/NRG1	3
hsa05152	Tuberculosis	4/41	180/8661	0.0100351217676332	0.0387467201583616	0.02464766749945	IL6/TNF/IL1A/IL1B	4
hsa05202	Transcriptional misregulation in cancer	4/41	193/8661	0.0127212609144035	0.0477906828946511	0.0304007373203385	NR4A3/IL6/NFKBIZ/CXCL8	4
hsa04010	MAPK signaling pathway	5/41	301/8661	0.0131867499079757	0.0482357430844374	0.0306838502013839	DUSP1/EREG/TNF/IL1A/IL1B	5
hsa05130	Pathogenic Escherichia coli infection	4/41	198/8661	0.0138662329917178	0.0494206765602249	0.0314376132605747	IL6/TNF/IL1B/CXCL8	4
hsa04931	Insulin resistance	3/41	108/8661	0.0142570879457142	0.0495433806113568	0.0315156680905261	SOCS3/IL6/TNF	3
hsa05219	Bladder cancer	2/41	41/8661	0.0159559705771642	0.0540946319567273	0.0344108222973502	HBEGF/CXCL8	2
hsa04930	Type II diabetes mellitus	2/41	46/8661	0.0198426394569082	0.0656696877264344	0.0417739778040174	SOCS3/TNF	2
hsa04068	FoxO signaling pathway	3/41	131/8661	0.0237318630249315	0.0767146269875694	0.0487999141761138	IL6/SGK1/PLK2	3
hsa05162	Measles	3/41	138/8661	0.027153896168155	0.085781626531217	0.0545676382326561	IL6/IL1A/IL1B	3
hsa05132	Salmonella infection	4/41	249/8661	0.0293794627419702	0.090749896025197	0.057728067142117	IL6/TNF/IL1B/CXCL8	4
hsa00590	Arachidonic acid metabolism	2/41	61/8661	0.0335598130221015	0.099705659168327	0.0634250312013591	PTGDS/PTGS2	2
hsa05010	Alzheimer disease	5/41	384/8661	0.0337134243231034	0.099705659168327	0.0634250312013591	IL6/TNF/IL1A/PTGS2/IL1B	5
hsa04148	Efferocytosis	3/41	156/8661	0.037105314812056	0.105257933854608	0.0669569590593493	MEGF11/SGK1/PTGS2	3
hsa04218	Cellular senescence	3/41	156/8661	0.037105314812056	0.105257933854608	0.0669569590593493	IL6/IL1A/CXCL8	3
hsa05020	Prion disease	4/41	272/8661	0.0387975547232668	0.106086305480526	0.067483905038729	IL6/TNF/IL1A/IL1B	4
hsa04217	Necroptosis	3/41	159/8661	0.0389237523705526	0.106086305480526	0.067483905038729	TNF/IL1A/IL1B	3
hsa05161	Hepatitis B	3/41	162/8661	0.0407873612824974	0.109027754197445	0.0693550272819794	IL6/TNF/CXCL8	3
hsa04920	Adipocytokine signaling pathway	2/41	70/8661	0.043127573594513	0.111013569067357	0.0706182491606061	SOCS3/TNF	2
hsa05204	Chemical carcinogenesis - DNA adducts	2/41	70/8661	0.043127573594513	0.111013569067357	0.0706182491606061	UGT2B17/PTGS2	2
hsa04622	RIG-I-like receptor signaling pathway	2/41	71/8661	0.0442471354093536	0.111824578580003	0.0711341507059464	TNF/CXCL8	2
